11 – 20 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome
(2025) In Heart
- Contribution to journal › Article
- 2024
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- Contribution to journal › Article
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
- Contribution to journal › Article
-
Mark
IL1RAP Blockade with a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis
- Contribution to journal › Article
-
Mark
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
(2024) In Journal of Cardiovascular Translational Research
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply
- Contribution to journal › Letter
